A novel drug reduces amyloid plaques and neuroinflammation in mice (IMAGE)
Caption
Compared with a control (left), treatment with the novel GSM (right) reduces the number of amyloid plaques (green) and proinflammatory cells called microglia (magenta) in the brains of mice carrying mutations linked to early-onset Alzheimer's disease.
Credit
©2021 Rynearson et al. Originally published in <em>Journal of Experimental Medicine</em>. https://doi.org/10.1084/jem.20202560
Usage Restrictions
Reporters may freely use these materials in news coverage with the appropriate credit information.
License
Licensed content